• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION; DEEP BRAIN STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION; DEEP BRAIN STIMULATOR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Atrial Fibrillation (1729)
Event Date 07/27/2016
Event Type  Injury  
Event Description
A report was received that the patient, during the implant procedure and during post-operative monitoring, experienced intermittent atrial fibrillation several times.It was decided that patient required oral anticoagulation and it was recommend that he be started postoperatively for four weeks as outpatient treatment.The event was assessed as unlikely related to study procedure, hardware and stimulation.
 
Manufacturer Narrative
Additional information was received that per the clinical study site, the event was reassessed as not related to the device, and there is no device component or device type potentially related to the event therefore the device information is not provided.
 
Event Description
A report was received that the patient, during the implant procedure and during post-operative monitoring, experienced intermittent atrial fibrillation several times.It was decided that patient required oral anticoagulation and it was recommend that he be started postoperatively for four weeks as outpatient treatment.The event was assessed as unlikely related to study procedure, hardware and stimulation.
 
Manufacturer Narrative
Additional information was received that per the investigator the event was not related to the procedure, device or stimulation.
 
Event Description
A report was received that the patient, during the implant procedure and during post-operative monitoring, experienced intermittent atrial fibrillation several times.It was decided that patient required oral anticoagulation and it was recommend that he be started postoperatively for four weeks as outpatient treatment.The event was assessed as unlikely related to study procedure, hardware and stimulation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
DEEP BRAIN STIMULATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key7527789
MDR Text Key108719324
Report Number3006630150-2018-01764
Device Sequence Number1
Product Code NHL
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/27/2018
Initial Date FDA Received05/18/2018
Supplement Dates Manufacturer Received05/25/2018
08/15/2018
Supplement Dates FDA Received06/04/2018
09/04/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-